C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,476 | -77.2% | 1,107 | -57.1% | 0.00% | -100.0% |
| Q4 2022 | $15,240 | -32.7% | 2,583 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,653 | +16.3% | 2,583 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,476 | -68.9% | 2,583 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $62,664 | -81.2% | 2,583 | -75.1% | 0.00% | -60.0% |
| Q4 2021 | $334,075 | -27.9% | 10,375 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $463,555 | +20.1% | 10,375 | +1.7% | 0.01% | +40.0% |
| Q2 2021 | $385,892 | +179.2% | 10,198 | +172.9% | 0.01% | +150.0% |
| Q1 2021 | $138,232 | +11.7% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $123,807 | – | 3,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |